Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-11-03

Clinical Trial Update: Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated P.Falciparum Malaria in Children [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluating fosmidomycin in combination with clindamycin for acute uncomplicated Plasmodium falciparum malaria in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clindamycin
  • Fosmidomycin (fosmidomycin)

Snippet

Sponsor: Jomaa Pharma GmbH | Conditions: Malaria | Phase 2 | Status: COMPLETED